Module contents

Module home

Module introduction

Module information

Related article: Advances in Psychiatric Treatment

About the authors

Pre-module test

 

Section 1: Indications for prescribing lithium

(1.1) Section 1: Indications for prescribing lithium

(1.2) History

(1.3) Indications for lithium use

(1.4) Treatment and prophylaxis of mania and bipolar affective disorder Type 1

(1.5) Treatment and prophylaxis of recurrent depression

(1.6) Lithium as a prophylactive agent in schizoaffective disorders

(1.7) Reducing suicidal risk and suicidal behaviour

(1.8) Other uses

(1.9) Contraindications and cautions

(1.10) Reflection

(1.11) Risks to the foetus

(1.12) Potential harm of the untreated psychiatric illness to mother and foetus

(1.13) Audio: NICE guidelines

(1.14) Reflection: suggested answers

(1.15) Further recommendations for pregnant and breastfeeding women

(1.16) Dosage

(1.17) Section 1: Recap

(1.18) Section 1: Summary

 

Section 2: Pharmacodynamics, pharmacokinetics and drug interactions

(2.1) Section 2: Pharmacodynamics, pharmacokinetics and drug interactions

(2.2) Pharmacodynamics

(2.3) Lithium's mechanism of action

(2.4) Other modes of action

(2.5) Pharmacokinetics

(2.6) Common drugs that lithium interacts with

(2.7) Section 2: Recap

(2.8) Section 2: Summary

 

Section 3: Lithium initiation and monitoring

(3.1) Section 3: Lithium initiation and monitoring

(3.2) Presentation: lithium and the National Patient Safety Agency (NPSA)

(3.3) Investigations required routinely before initiation of lithium treatment

(3.4) Investigations required routinely for monitoring patients on lithium

(3.5) Reflection

(3.6) Section 3: Recap

(3.7) Section 3: Summary

 

Section 4: Management of side-effects and toxic effects

(4.1) Section 4: Management of side-effects and toxic effects

(4.2) Side-effects

(4.3) Lithium level

(4.4) Toxic effects

(4.5) Management of side-effects and toxic effects

(4.6) Lithium's effect on the thyroid

(4.7) Interactive exercise: effect on kidney function (interactive)

(4.8) Estimated Glomerular Filtration Rate (eGFR)

(4.9) Section 4: Recap

(4.10) Section 4: Summary

 

Module summary

Module test

Acknowledgements

Send feedback

 

Useful resources

References

Further reading

Take-home notes

 

© 2021 Royal College of Psychiatrists